St. Louis-based Washington University has won more than $31.6 million from a patent victory over the University of Wisconsin’s technology transfer office.
A Minnesota judge has approved an agreement between 3M and a former Marine, resolving a price-gouging dispute over N95 masks.
Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.
Discretionary denials at the Patent Trial and Appeal Board, the CRISPR landscape and section 101 are top of mind for Eldora Ellison, director at Sterne Kessler Goldstein & Fox.
Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.
The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.
The English High Court has lifted a stay on Amgen’s lawsuit which accused Sanofi-Aventis and Regeneron of infringing a patent covering pharmaceuticals which treat elevated cholesterol levels.
Swiss pharmaceutical company Roche will pay $350 million for the rights to develop and distribute an investigational COVID-19 antiviral outside of the US.
Pharmaceutical company Eli Lilly’s subsidiary Dermira has accused generic drugmaker Perrigo of infringing eight patents for Qbrexza, a prescription-only cloth towelette approved to treat hyperhidrosis, a condition that causes excessive underarm sweating.
US biotechnology company Seagen has accused Japanese pharmaceutical company Daiichi Sankyo of infringing patents with a recently-approved breast cancer drug.